M&A / Deals Shionogi secures $482m BARDA contract to tackle AMR crisis Pharmaceutical TechnologyShionogi will use the money from BARDA to build an American antibiotic manufacturing site as the US looks to fight antimicrobial resistance.M&A / DealsInfectious DiseaseRead full story pharminent April 9, 2026 (Last updated: April 9, 2026) Pharmaceutical Technology Shionogi will use the money from BARDA to build an American antibiotic manufacturing site as the US looks to fight antimicrobial resistance. M&A / DealsInfectious DiseaseRead full story Post navigation Previous: Sidewinder secures $137M to advance ‘precision’ ADCsNext: Syneron raises $150m for macrocyclics, and other financings Related Stories M&A / Deals BioMarin spends up to $490m for Alesta’s bone disease candidate pharminent August 19, 2026 M&A / Deals J&J hands lymphoma bispecific CAR T back to AbelZeta pharminent August 17, 2026 M&A / Deals Novo Nordisk and AWS form AI partnership to speed drug discovery pharminent August 17, 2026
